SPHRY OTC
Starpharma Holdings Limited
1W: -12.2%
1M: -4.7%
3M: +9.8%
YTD: +94.2%
1Y: +197.1%
3Y: +127.5%
5Y: -51.0%
$5.05
-0.80 (-13.68%)
Weekly Expected Move ±13.3%
$4
$4
$5
$6
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+52.5% ▲
Capital Expenditures
$287K
-583.3% ▼
5Y CAGR: +3.1%
Free Cash Flow
-$3M
+48.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4M
+44.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$16M | -$16M | -$8M | -$10M | -$7M |
| Depreciation & Amort. | $1M | $1M | $0 | $1M | $911K |
| Stock-Based Comp. | $2M | $2M | $0 | $871K | $0 |
| Change in Working Capital | -$140K | -$1M | $2M | $2M | $629K |
| Other Non-Cash Items | $4M | $6M | -$1M | -$1M | $3M |
| Operating Cash Flow | -$13M | -$14M | -$7M | -$7M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$837K | -$621K | -$89K | -$42K | -$287K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $1K | $11K | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $28K |
| Investing Cash Flow | -$836K | -$610K | -$89K | -$42K | -$259K |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | $83K | -$4M | -$1M | -$876K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$772K | -$778K | -$745K | $0 | $0 |
| Financing Cash Flow | $3M | -$695K | -$5M | -$1M | -$876K |
| Net Change in Cash | -$11M | -$15M | -$12M | -$8M | -$4M |
| Cash End of Period | $50M | $35M | $23M | $15M | $11M |
| Free Cash Flow | -$14M | -$14M | -$7M | -$7M | -$3M |